This article presents guidelines for initial imaging utilization in patients presenting with
sinonasal disease, including acute rhinosinusitis without and with suspected orbital and …

Sinonasal imaging is performed in 2 major clinical scenarios: inflammatory rhinosinusitis or
suspected mass lesion. Rhinosinusitis affects more than 16% of the US population annually …

Imaging of sinonasal pathology may occur for assessment of rhinosinusitis or mass lesions.
Rhinosinusitis is prevalent in up to 16% of the US population with annual economic burdens …

Although malignancies in the sinonasal cavity comprise only 3% of all head and neck
cancers and 1% of all malignancies, 1 they are important disease entities to consider …

Abstract The American College of Radiology (ACR) Appropriateness Criteria are evidence‐
based guidelines for specific clinical conditions that are reviewed annually by a …

Computed tomography (CT) is often the primary imaging modality for the evaluation of
sinonasal disease. For some indications, magnetic resonance imaging (MRI) may provide …

Background Knowledge of medial orbital wall (MOW) and anterior skull base (ASB)
infiltration is of uttermost importance for staging and therapy planning of advanced sinonasal …

Acute rhinosinusitis is a symptomatic inflammation of the nasal cavity and paranasal sinuses
lasting less than 4 weeks [1]. In subacute rhinosinusitis, symptoms last from 4 to 12 weeks …

Objective The overall discriminatory ability of validated instrument scores for computed
tomography (CT) findings of chronic rhinosinusitis has limitations and may be modified by …

Objective The 22-item Sinonasal Outcome Test (SNOT-22) is a trusted measure of symptom
severity in chronic rhinosinusitis. The European Position Paper on Rhinosinusitis (EPOS) …